SEC Form 4 · accession 0001209191-18-047878
C. H. ROBINSON WORLDWIDE, INC. · CHRW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Wiehoff
Officer — CEO/Chairman · Director
Period of report
Feb 3, 2016
Accepted (ET)
Aug 21, 2018 · 8:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001043277
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2016 | F | 11,453 | $64.77 | D | 715,727 | D | |
| Common StockF1,F2 | Aug 17, 2018 | S | 30,000 | $96.4471 | D | 685,727 | D | |
| Common Stock | Aug 9, 2018 | G | 10,000 | $0.00 | D | 36,000 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3 | $68.81 | Feb 3, 2017 | A | 3,169 | A | — | Dec 7, 2021 | Common Stock | 3,169 | 41,830 | D |
| Option (right to buy)F4 | $61.91 | Feb 3, 2017 | A | 5,495 | A | — | Dec 5, 2022 | Common Stock | 5,495 | 46,158 | D |
| Option (right to buy)F4 | $61.91 | Feb 2, 2018 | A | 1,099 | A | — | Dec 5, 2022 | Common Stock | 1,099 | 47,257 | D |
| Option (right to buy)F5 | $58.25 | Feb 3, 2017 | A | 15,216 | A | — | Dec 4, 2023 | Common Stock | 15,216 | 78,616 | D |
| Option (right to buy)F5 | $58.25 | Feb 2, 2018 | A | 11,412 | A | — | Dec 4, 2023 | Common Stock | 11,412 | 90,028 | D |
| Option (right to buy)F6 | $74.57 | Feb 3, 2017 | A | 14,354 | A | — | Dec 3, 2024 | Common Stock | 14,354 | 44,259 | D |
| Option (right to buy)F6 | $74.57 | Feb 2, 2018 | A | 10,766 | A | — | Dec 3, 2024 | Common Stock | 10,766 | 55,025 | D |
Explanation of responses
- F1Reflects the weighted average price of 30,000 shares of common stock of C.H. Robinson Worldwide, Inc. sold by the reporting person in multiple transactions on August 17, 2018 with sale prices ranging from $96.35 to $96.56 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Included in this amount are 605,727 shares of Issuer common stock issuable in settlement of an equal number of deferred shares and vested performance restricted stock units credited to the reporting person's NQDC Plan account, and 80,000 shares held directly by the reporting person.
- F3Performance-based stock option granted 12/7/11 that vests, becomes exercisable and reportable as and to the extent applicable performance conditions are satisfied.
- F4Performance-based stock option granted 12/5/12 that vests, becomes exercisable and reportable as and to the extent applicable performance conditions are satisfied.
- F5Performance-based stock option granted 12/4/13 that vests, becomes exercisable and reportable as and to the extent applicable performance conditions are satisfied.
- F6Performance-based stock option granted 12/3/14 that vests, becomes exercisable and reportable as and to the extent applicable performance conditions are satisfied.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney